‘In A Word, Complicated’ – AAM’s Burton Talks US Biosimilars

Biosimilars Council Chief Sees Improvement In US Market, But Says There Is Further To Go

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".